Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of atomoxetine oral solution vs capsule in healthy Japanese males
jRCT1080221208Phase 1Recruiting
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of atomoxetine, sponsored by Eli Lilly and Company. Primary endpoint: Primary pharmacokinetic bioequivalence endpoints. Started Aug 2010; status: recruiting.
02
Drugs
atomoxetine
Beyond the preview
Go deeper on jRCT1080221208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080221208.